Prefilled Syringes Market to Register 10.4% CAGR till 2026
The global prefilled syringes market size is projected to reach USD 9.53 billion by 2026, exhibiting a CAGR of 10.4% during the forecast period. Rising incidence of cancer and other Non-Communicable Diseases (NCDs) is expected to be the primary factor fueling the prefilled syringe market growth. According to the World Health Organization (WHO), 9 million deaths are caused by cancer worldwide every year. In total, NCDs cause close to 41 million deaths, or 71% of the global deaths, annually, states the WHO. The National Cancer Institute estimates that in the US alone, 1,735,530 new cancer cases were reported in 2018; by 2030, this figure is anticipated to reach 23.6 million. Such widespread prevalence of cancer and other NCDs has generated the need for alternative solutions such as biological drugs. The administration of these drugs requires modern devices such as prefilled syringes, which is foreseen to augment the prefilled syringes market potential in the forthcoming years.
Fortune Business Insights™ provides the above information in its new report, titled “Prefilled Syringes Market Size, Share & Industry Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories) By Design (Double-chamber, Multiple-chamber, and Single-chamber) By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others) and Regional Forecast, 2019-2026”.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946
Rising Instances of Opportunistic Infections and Injuries at Hospitals to Boost the Market
Infections and injuries caused by needle stickscan be hazardous as they can cause serious damage to the body. According to the National Institute for Occupational Safety and Health (NIOSH), USA, a needle stick injury is one that is caused by sharp and pointed objects such as blood collection and hypodermic needles. Increasing workload of healthcare professionals at medical facilities such as hospitals has upped the threat of opportunistic injuries for these people, thereby expanding the prefilled syringes market size. For example, the US Centers for Disease Control and Prevention (CDC) numbered the injuries caused by sharp objects in US hospitals at 600,000. Thus, as patient care gets more complex and demanding, safety concerns regarding needle stick injuries are expected to gain prominence and lead the prefilled syringes market trends in the upcoming years.
Europe to Lead the Pack; Asia-Pacific to Grow at a Remarkable Pace
Among regions, Europe is slated to dominate the prefilled syringes market share during the forecast period, with the region’s market size having stood at USD 1.76 billion in 2018. Factors propelling the market in Europe include growing uptake of self-injectable drug devices and increasing preference for biological drugs for treating chronic diseases.
Asia-Pacific is forecasted to showcase high-paced growth on account of increasing prevalence of chronic diseases and a speedily growing patient population. North America is projected to hold the second-largest section of the prefilled syringe market share owing to a strong presence of major market players and rising incidence of cancer.
More Trending Topics from Fortune Business Insights :
Ophthalmic Lasers Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
Global Intraocular Lens (IOL) Market to Showcase 6.8% CAGR
The global intraocular lens (IOL) market size is projected to reach USD 5,318.8 million by 2026, thereby exhibiting a CAGR of 6.8% during the forecast period. However, the market was worth USD 3,159.3 million in 2018. This information is published in a recent report by Fortune Business Insights™, titled, “Intraocular Lens (IOL) Market Size, Share & Industry Analysis, By Type [Monofocal Intraocular Lens and Premium Intraocular Lens (Multifocal Intraocular Lens, Toric Intraocular Lens, and Others)], By Material [Polymethyl methacrylate (PMMA) and Foldable (Hydrophobic Acrylic, Hydrophilic Acrylic, and Silicone & Collamer)], By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics, and Academic & Research Institutes) and Regional Forecast, 2019-2026.”The report further states that the market is set to gain impetus from the rising number of NGOs offering free cataract surgeries and eye examinations.
Rising Government Initiatives to Eliminate Cataract Will Boost Growth
The incidence of cataracts is rising at a rapid rate nowadays. It is, in turn, causing huge health as well as an economic burden in several countries. Therefore, the governments of these countries are launching various initiatives to eliminate cataracts. One such global initiative is called ‘Vision 2020’. It was put forward by the International Agency for the Prevention of Blindness (IAPB)toremove the major causes of avoidable blindness from the world. Additionally, the governments are conducting eye checkup camps and launching favorablereimbursement policies to achieve their target of Vision 2020. It is expected to augment the intraocular lens market growth during the forecast period.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/intraocular-lens-market-101220
Monofocal IOL Segment to Lead Stoked by Favorable Government Reimbursement Policies
By type, the market is grouped into premium intraocular lens and monofocal intraocular lens. Amongst these, the monofocal intraocular lensis expected to lead by gaining the maximum IOL market share in the coming years. This growth is attributable to the rising number of favorable government reimbursement policies as well as cost-effective nature.
The premium intraocular lens segment, on the other hand, consists of sub-segments, namely, toric intraocular lens, multifocal intraocular lens, and others. This segment has less penetration as compared to monofocal IOLs. This mainly occurs as multiple government-aided insurance policies do not cover the cost of premiumintraocular lens. Thus, the patient has to pay for the same from their expenses. However, this segment is anticipated to showcase growth during the forecast period owing to the rising preference for toric lenses and their possession of numerous benefits.
More Trending Topics from Fortune Business Insights :
Sedation In ICU Setting Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
 Market to Showcase 6.8% CAGR)
Recombinant Vaccines Market to Reach $21 Billion by 2026
The global recombinant vaccines market size is projected to reach USD 21.00 billion by the end of 2026. The advancements in molecular genomics have opened up a huge potential for market growth. According to a report by Fortune Business Insights, titled “Recombinant Vaccines Market Size, Share & Industry Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus, Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026,” the market size was USD 8.97 billion in 2018. Driven by increasing number of regulatory approvals, the market will exhibit a CAGR of 11.3% during the forecast period, 2019-2026
Increasing Number of Regulatory Approvals Will Aid Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the increasing number of regulatory clearances have made the highest impact on the market in recent years. In December 2019, Merck received approval from the US Food and Drug Administration for a new vaccine. The ERVEBO was the first ever Ebola vaccine. The approval for ERVEBO will encourage several manufacturers. In October 2017, the USFDA approved GlaxoSmithKline’s new vaccine SHINGRIX which is used for the treatment of herpes zoster. The report highlights the importance of these vaccines on the global market. The report includes a few of the other drug approvals of recent years and gauges their impact on the market.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/recombinant-vaccines-market-101935
North America to Emerge Dominant; Emphasis on Product R&D to Aid Growth
The report offers insights into the ongoing recombinant vaccine market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America is likely to emerge dominant in the coming years. The demand for recombinant vaccines has risen dramatically across this region, due to the efficacy provided by the recombinant vaccines in treating complex viral diseases. As of 2018, the market in North America was worth USD 4.12 billion in 2018 and this value is likely to increase further in the coming years. Besides North America, Europe will witness considerable growth due to lesser adoption of immunization policies in under-developed European countries.
More Trending Topics from Fortune Business Insights :
Acute Bacterial Skin and Skin Structure Infections Treatment Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
Diabetic Foot Ulcer Treatment Market to Gain from Technologically Advanced Treatment Options
The global diabetic foot ulcer treatment market size is prophesized to reach USD 11.09 billion by 2026 owing to the increasing prevalence of diabetic foot ulcers among diabetic patients worldwide. A report published by Fortune Business Insights™ titled, “Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026,”states that market value was USD 6.62 billion in 2018. It is likely to exhibit a CAGR of 6.8% and grow steadily within the forecast duration, 2019- 2026.
Rising Geriatric Population and Increasing Cases of Diabetic Foot Ulcer to Boost Market
The increasing prevalence of diabetes is a major factor augmenting the diabetic foot ulcer treatment market growth. In addition, the rise in the geriatric population and their vulnerability to various issues are also opening doors of opportunity for the market. As per the article published by the National Center for Biotechnology Information, diabetic foot ulcer is 13% prevalent in North America. It also states the yearly incidence of necrosis or diabetic foot ulcer is about 2-5%, and the lifetime risks vary between 15 to 20%. The above figures indicate a large number of the patient pool for availing treatment options for a diabetic foot ulcer. This, in turn, is anticipated to help increase the overall diabetic foot ulcer treatment market size during the forecast period.
The increasing awareness about diabetic ulcers and the availability of treatment options for this ulcer is anticipated to further attract high diabetic foot ulcer treatment market revenue in the coming years. Furthermore, ongoing clinical trials that yielded favorable results for treating diabetic foot ulcer is further prognosticated to increase the overall diabetic foot ulcer treatment market growth in the near future.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948
High Product Cost to HelpNorth America Earn Dominate Share
In terms of geographical outlook, North America earned the dominant diabetic foot ulcer treatment market share in the year 2018. This is owing to the rising prevalence of foot ulcers among people with diabetes, and the high cost of products. Additionally, the advent of advanced technologies for therapeutic procedures and high expenditure on health is also responsible for the region to dominate the market.
On the other side, Europe ranked second largest diabetic foot ulcer treatment market share on account of the rise in adoption of advanced options for treatment in nations such as U.K., France, and Germany. Furthermore,the increasing geriatric population and rising prevalence of diabetic foot ulcers in Asia Pacific are likely to help this region witness a high CAGR in the forecast period.
Players to Focus on Geographical Expansion for Earning Lion’s Share in Market
Currently, the market is dominated by four significant players namely Mölnlycke Health Care AB., Coloplast Corp, ConvaTec Group Plc, and Smith & Nephew. This dominance is attributed to the strong presence of the brand and the presence of a wide range of product offerings. Besides this, there is continuous investment in product development and robust speed in research activities which will further help to attract high diabetic foot ulcer treatment market revenue in the forecast period. In addition, Players are also stressing on entering into strategic partnerships for expanding their geographical boundaries worldwide.
More Trending Topics from Fortune Business Insights :
Plasma Fractionation Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
High Prevalence of Colorectal Cancer Worldwide to Drive Global Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.
According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%.As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/colorectal-cancer-therapeutics-market-101945
Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth
Geographically, North America is leading the market with a high prevalence of colorectal cancer. In 2018, North America earned USD 4.13 billion, owing to the new product launches in and around the region. Thus, the factors mentioned above are likely to help this region continue dominating the market in the future too.
On the other side, the continuously improving healthcare infrastructure, coupled with the rise in disposable incomes of people in Asia Pacific is expected to boost the regional market in the forecast period. Colorectal cancer is a major reason for the rise in mortality rates, coupled with the rising awareness about colorectal cancer therapeutics that will help this region attract high colorectal cancer therapeutics market revenue in the near future.
Merck Sharp & Dohme Corp, Genentech, Inc., and Bristol Myers Squibb Holding Leading Market Position
Major vendors in the colorectal cancer therapeutics market are focusing on research and development of novel colorectal cancer therapeutics. Currently, companies such as Bristol Myers Squibb, Genentech, Inc., and Merck Sharp & Dohme Corpare dominating the market. This is owing to the robust pipeline candidates, key strategic decisions, and the presence of a strong oncology portfolio. The overall colorectal cancer therapeutics market is subject to a number of biosimilar launches and has a strong presence of generics, especially for chemotherapy.
Microfluidic Devices Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
Examination Lights Market to Reach $259.6 Million by 2026
The global examination lights market size is set to reach USD 259.6 million by 2026, exhibiting a CAGR of 3.5% during the forecast period. Increasing patient burden on healthcare facilities worldwide will act as the central growth driver for this market in the upcoming decade. The incidence of various kinds of diseases and disorders is rising at a rapid rate around the world. For instance, close to 463 million people were diabetic in 2019, according to the International Diabetes Federation (IDF). By 2045, IDF expects this number to reach 700 million. Similarly, the World Health Organization states that 18.1 million new cancer cases were reported in 2018 and the diseases caused 9.6 million deaths in the same year. Widespread prevalence of these chronic and life-threatening diseases has compelled governments across the globe to increase their healthcare spending. As a result, healthcare infrastructures globally are getting more robust and technologically advanced, making this factor one of the leading examination lights market trends.
Fortune Business Insights™, through its report, titled “Examination Lights Market Size, Share & Industry Analysis, By Technology (LED, and Halogen), By End User (Hospitals, Clinics, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 197.1 million in 2018.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/examination-lights-market-101944
Few Disadvantages of LED Lights to Put Constraints on Growth
Light Emitting Diodes or LEDs are a landmark advancement in lighting technology as these lights are extremely energy-efficient and have a significantly longer shelf-life compared to conventional halogen lights. However, they suffer from a few limitations which may hold back the examination lights market growth. For instance, the performance of LED lights is dependent on ambient temperature. High ambient temperatures may cause overdriving of LEDs and damage the device. To avoid this situation, effective heat-sinking mechanisms need to be deployed. This factor is vital in the healthcare industry as these lights need to function efficiently across different temperatures in a healthcare facility. Furthermore, LEDs are known to cause ‘blue pollution’ since they emit large quantities of blue light, which is the most intense form of visible light, thereby causing greater amount of light pollution.
North America to Occupy the Driver’s Seat; Asia-Pacific to Grow at a Considerable CAGR
With a market size of USD 63.8 million in 2018, North America is poised to dominate the examination lights market share in the forecast period. The main forces driving the growth of this market include increasing focus on early diagnosis of diseases, high prevalence of chronic disorders such as obesity, and active adoption of advanced healthcare technologies in the region.
Asia-Pacific is anticipated to display a healthy CAGR on account of improving healthcare infrastructure in India and China coupled with entry of private players in the health sector. In Latin America and the Middle East & Africa, the market will be fueled by the rising government expenditure in developing healthcare infrastructure.
More Trending Topics from Fortune Business Insights :
Neurovascular Devices Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
HPV Vaccines Market to Exhibit an Exceptional CAGR of 16.3%
The global human papillomavirus vaccines market size is projected to reach USD 11.15 billion by 2026, exhibiting a CAGR of 16.3% during the forecast period. The increasing incidence of HPV associated cancers such as anal, oropharynx, and genital parts and growing demand for HPV vaccines to help reduce the infections are factors likely to bolster healthy growth of the market in the forthcoming years. Additionally, growing cases of cancer observed in females will spur demand for HPV vaccines in the foreseeable future. According to the Center for Disease Control and Prevention (CDC), higher incidence rates for vaginal, vulva and cervical cancer was recorded in the year 2018.
According to the report, published by Fortune Business Insights, in a report, titled “Human Papillomavirus Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026” the HPV vaccines market size was valued at USD 3.32 billion in 2018. The report incorporates several factors that have impacted the growth of the human papillomavirus vaccines market shares in recent years. Besides growth stimulators, it reveals a few of the factors that have restricted the market growth. The report highlights a few of the leading products, significant companies, and considerable industry developments of recent times. The competitive landscape in themarket size has been discussed in-depth. Forecast values for the market have been provided in the report for the period of 2019 to 2026. Moreover, the report recognizes areas that have witnessed the highest demand and applications for the product in recent years.Nonetheless, the figures and topics covered in this report are both all-inclusive and reliable for the readers.
For More Information : https://www.fortunebusinessinsights.com/human-papillomavirus-hpv-vaccines-market-101962
Increasing Effectiveness and Enhancement of Vaccines to Promote Healthy Growth
The growing efficacy and improvement in vaccines for reducing the adverse effects associated with HPV infections will have a positive impact on the HPV vaccines market revenue in the forthcoming years. Furthermore, the rising focus of manufacturers towards the development of novel vaccines to immunize against HPV infections will create lucrative business opportunities in the foreseeable future. Furthermore, the growing cases of cervical cancer around the world has led to an increase in sales of HPV vaccines. For instance, Merck’s Gardasil sales grew from US$ 1.7 billion in 2014 to US$ 3.2 billion in 2018. Additionally, the penetration of vaccines doses in the developing and low-income countries through the immunization programs by international organizations such as GAVI/PAHO/WHO will boost the HPV vaccines market share during the forecast period.
Mass Vaccination of Girls in Kenya to Spur Growth Opportunities
The increasing manufacturing of HPV vaccines to maintain a supply-demand balance will surgethe market’s revenue during the forecast period. The introduction of the HPV vaccine by the Ministry of Health of Ethiopia is predicted to facilitate the healthy growth of the market in the forthcoming year. For instance, in December 2018, the Ministry of Health of Ethiopia introduced the HPV vaccine through a school-based approach for girls of 14 years of age to immunize against cervical cancer.
Examination Lights Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
Global NPWT Market to Reach USD 2.74 Billion by 2026
The global negative pressure wound therapy (NPWT) market size is projected to reach USD 2.74 billion by 2026, exhibiting a CAGR of 5.1% during the forecast period. However, it stood at USD 1.85 billion in 2018.Fortune Business Insights™ published this information in a recent study, titled, “Negative Pressure Wound Therapy (NPWT) Market Size, Share & Industry Analysis, By Device Type (Conventional NPWT, and Single-use NPWT), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Burns & Trauma, and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others) and Regional Forecast, 2019-2026.” As per the study, there is an increasing incidence of surgical site infections and chronic wounds amongst the masses worldwide. Thus, such factors would affect the market positively in the coming years.
Increasing Cases of Diabetic Foot Ulcer to Drive Growth
Nowadays, there exists a large patient pool across the world that are affected by chronic diseases, such as diabetes. Such conditions are further giving rise to diabetic foot ulcers. As per a published report byNHS, for instance, approximately 4.5 million people were affected by diabetes in the U.K. in 2017. Also, around 10.0% of that diabetic population developed foot ulcer at some point in their lives. Additionally, as the geriatric population is rising, the cases of various conditions and diseases is also upsurging. It is, in turn, causing reduced mobility amongst the affected populaces. These would contribute to the vacuum assisted closure devices market growth during the forecast period.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/negative-pressure-wound-therapy-npwt-devices-market-101243
North America to Grow Significantly Stoked by High Treatment Cost
In terms of region, the market is grouped into the Middle East and Africa, North America, Asia Pacific, Europe, and Latin America. Out of these, North America had acquired USD 738.1 millionNPWT market revenue in 2018 and is expected to expand steadily in the forthcoming years. This growth is attributable to the high treatment cost and rising incidence of chronic wounds in the U.S. Europe would showcase a slow growth owing to the inadequate reimbursement policies in countries, namely, Italy, Spain, and France.
Asia Pacific, on the other hand, is anticipated to grow significantly by exhibiting a high CAGR. It is likely to occur because of the rising patient pool affected by chronic wounds, as well as an increasing prevalence of chronic diseases. The Middle East & Africa and Latin America would show a moderate CAGR on account of the unavailability of favorable reimbursement policies and expensive nature of treatments.
More Trending Topics from Fortune Business Insights :
Human Insulin Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
Pet Insurance Market to Reach $11.25 Billion by 2026
The global pet insurance market size is projected to reach USD 11.25 billionby 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billionin 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.
The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.
For More Information : https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956
Increasing Number of Company Mergers and Collaborations to Aid Market Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. It highlights a few of the leading market drivers and analyzes their impact on the market. Among all factors, the increasing number of company mergers and collaborations have had a positive impact on market growth. In October 2019, Petplan, a leading pet insurance provider, announced that it has been acquired by WarnbugPincus. Warnbug is a leading private equity firm that mainly focuses on growth-oriented investing. With this acquisition, the company will look to outperform its counterparts and in doing so, establish a strong presence in the market. The report highlights a few of the other company mergers that have graced the market in recent years and gauges their impact on the market.
Europe to Emerge Dominant; Influx of Start-ups to Aid Growth
The report analyzes the ongoing pet insurance market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Europe generated the highest market revenue in 2018. Europe is projected to dominate the market in the coming years driven by the increasing number of start-ups in several countries across this region. The increasing number of government initiatives to promote animal wellness and health, coupled with encouragement for pet adoption, will aid the growth of the market in this region. Besides Europe, the market in North America will exhibit considerable CAGR. As of 2018, the market in North America was worth USD 1.42 billion and this value is likely to increase further in the coming years.
More Trending Topics from Fortune Business Insights :
Trauma Implants Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
